7101 - 7150 of 9156 Results
Title
Year
-
OPENTitle: Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 956End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12697Best OA location URL: https://doi.org/10.1002/alz.12697Citation Count: 60
-
OPENTitle: Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseasesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 6Start Page: 2618End Page: 2632Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12880Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11633037Citation Count: 28
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 52
-
OPENTitle: 146th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: S27Start Page: S1End Page: S270Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26180Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26180Citation Count: 17
- Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model2023OPENTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 15
- Neural Correlates of Optimal Deep Brain Stimulation for Cervical Dystonia2022RESTRICTEDTitle: Neural Correlates of Optimal Deep Brain Stimulation for Cervical DystoniaJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 3Start Page: 418End Page: 424Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26450Citation Count: 19
- 147th Annual Meeting American Neurological Association2022RESTRICTEDTitle: 147th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: S29Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26484Citation Count: 25
- Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits2022RESTRICTEDTitle: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock BenefitsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 12Start Page: 1219End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649Citation Count: 7
-
OPENTitle: Multishank Thin‐Film Neural Probes and Implantation System for High‐Resolution Neural Recording ApplicationsJournal Name: Advanced Electronic MaterialsPublisher: WileyVol: 9Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/aelm.202200883Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/aelm.202200883Citation Count: 21
- Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau2021RESTRICTEDTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 2
- Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's disease2022RESTRICTEDTitle: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.067067Citation Count: 6
- Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease2022RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21008Citation Count: 5
- Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply2022RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—ReplyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21011Citation Count: 4
-
OPENTitle: Machine Learning for Predicting Rare Clinical Outcomes—Finding Needles in a HaystackJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 5Start Page: e2110738End Page: e2110738Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.10738Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780278/wang_2021_ic_210094_1620949822.15523.pdfCitation Count: 22
- Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases2020RESTRICTEDTitle: Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare DiseasesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4232Citation Count: 3
- Ischemic Events After Intracerebral Hemorrhage2021RESTRICTEDTitle: Ischemic Events After Intracerebral HemorrhageJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 795End Page: 795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772Citation Count: 3
- Bad Air and Parkinson Disease—The Fog May Be Lifting2021RESTRICTEDTitle: Bad Air and Parkinson Disease—The Fog May Be LiftingJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 793End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0863Citation Count: 7
- Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?2021RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 5
- Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease2021OPENTitle: Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 12Start Page: 1443End Page: 1443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.3744Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2785852/jamaneurology_de_vries_2021_ed_210020_1638811688.29228.pdfCitation Count: 15
- Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease2022RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
- Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply2022RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
OPENTitle: Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal ControlsJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 20Issue #: 9Start Page: 4303End Page: 4317Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.1c00290Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11060066Citation Count: 48
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022OPENTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 24
- A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue2021OPENTitle: A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in TissueJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 125Issue #: 50Start Page: 13710End Page: 13717Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jpcb.1c07762Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7615715Citation Count: 9
- PINK1/Parkin-Mediated Mitophagy Plays a Protective Role in the Bone Impairment Caused by Aluminum Exposure2021RESTRICTEDTitle: PINK1/Parkin-Mediated Mitophagy Plays a Protective Role in the Bone Impairment Caused by Aluminum ExposureJournal Name: Journal of Agricultural and Food ChemistryPublisher: American Chemical Society (ACS)Vol: 69Issue #: 21Start Page: 6054End Page: 6063Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jafc.1c01921Citation Count: 29
-
OPENTitle: Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological WorkflowJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 93Issue #: 32Start Page: 11108End Page: 11115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acs.analchem.1c01128Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.1c01128Citation Count: 8
-
OPENTitle: Thyrotoxicosis Resulting in Unilateral Upper Limb Chorea and BallismusJournal Name: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesPublisher: Cambridge University Press (CUP)Vol: 49Issue #: 3Start Page: 431End Page: 432Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/cjn.2021.136Citation Count: 3
-
OPENTitle: The Records of the Human Sciences Research CouncilJournal Name: History in AfricaPublisher: Cambridge University Press (CUP)Vol: 48Issue #:Start Page: 397End Page: 411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/hia.2021.15Citation Count: 1
-
OPENTitle: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learningJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 3Issue #: 9Start Page: e555End Page: e564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1Best OA location URL: http://www.thelancet.com/article/S2589750021001011/pdfCitation Count: 90
-
OPENTitle: Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gapJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 4Issue #: 11Start Page: e768End Page: e769Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(22)00190-xBest OA location URL: http://www.thelancet.com/article/S258975002200190X/pdfCitation Count: 4
- The East Asian Parkinson Disease Genomics Consortium2021OPENTitle: The East Asian Parkinson Disease Genomics ConsortiumJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 982End Page: 982Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00373-2Citation Count: 9
- Movement disorders research in 2021: cracking the paradigm2021RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 19
- Major advances in Parkinson's disease over the past two decades and future research directions2022RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 18
- Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial2022RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 204
- Revisiting levodopa for advanced Parkinson's disease2022RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 2
- Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein2022RESTRICTEDTitle: Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synucleinJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S87End Page: S88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00207-4Citation Count: 0
- Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors2022RESTRICTEDTitle: Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursorsJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S88End Page: S89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00209-8Citation Count: 0
- Back to the Office2022RESTRICTEDTitle: Back to the OfficeJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 28End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834412.51769.b3Citation Count: 0
- The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and Prevention2021RESTRICTEDTitle: The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and PreventionJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 9Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000752844.66769.73Citation Count: 0
- How Flavonoids Affect Parkinson's Disease2022RESTRICTEDTitle: How Flavonoids Affect Parkinson's DiseaseJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834392.64279.cfCitation Count: 0
- Group Exercise Classes Are Fun and Motivating2022RESTRICTEDTitle: Group Exercise Classes Are Fun and MotivatingJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834396.10260.d4Citation Count: 0
- Table for One2022RESTRICTEDTitle: Table for OneJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 4Start Page: 30End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000856280.92010.9bCitation Count: 0
- New Questions About a Mysterious Neurologic Cluster in Canada2021RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
-
OPENTitle: Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia are more frequent in advanced versus early Parkinson’s diseaseJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab067Best OA location URL: https://academic.oup.com/sleep/article-pdf/44/9/zsab067/45297401/zsab067.pdfCitation Count: 26
- Novel Genes May Drive Progression in Parkinson's Disease2021RESTRICTEDTitle: Novel Genes May Drive Progression in Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 12Start Page: 25End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000756456.16968.c1Citation Count: 0
- Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?2021RESTRICTEDTitle: Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792796.54034.5fCitation Count: 0
- Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorder2021OPENTitle: Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorderJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab167Citation Count: 12
- Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 20202021RESTRICTEDTitle: Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020Journal Name: Operative NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 5Start Page: 277End Page: 290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/ons/opab261Citation Count: 20
- Bending curvatures of subducting plates: old versus young slabs2021RESTRICTEDTitle: Bending curvatures of subducting plates: old versus young slabsJournal Name: Geophysical Journal InternationalPublisher: Oxford University Press (OUP)Vol: 225Issue #: 3Start Page: 1963End Page: 1981Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/gji/ggab070Citation Count: 6
-
OPENTitle: LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 5Start Page: 1509End Page: 1525Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab073Best OA location URL: https://academic.oup.com/brain/article-pdf/144/5/1509/38813669/awab073.pdfCitation Count: 29